Le Lézard
Classified in: Health, Covid-19 virus
Subject: PDT

Solv Announces New COVID-19 Vaccine Scheduling and Logistics Solution


SAN FRANCISCO, Jan. 28, 2021 /PRNewswire/ -- Solv, the leading digital healthcare platform for convenient care, today announced Solv for Vaccines, a scalable scheduling and logistics solution that enables hospitals, urgent care clinics and public health organizations to power high volume COVID-19 vaccination sites in every community across the country.

New tech solution is accelerating vaccine delivery for hospitals, clinics, and government health organizations.

The world has embarked on one of the largest mass vaccination campaigns in human history. Accelerating vaccinations is critical to saving lives and reopening the country and economy, but the initial roll out has proven that quickly vaccinating millions of people is a tough logistical challenge for healthcare organizations and their partners in the public health community. Traditional healthcare technology and EMRs were not built to handle high volume vaccine scheduling or deliver clear and friendly patient experiences. Solv for Vaccines gives government officials and healthcare workers a solution that can easily flex to accommodate the surges in appointment volumes required to move through each phase of COVID-19 vaccine delivery. 

"Mass COVID-19 vaccination has presented government agencies and healthcare workers with the difficult challenge of scaling operations to treat thousands of patients each day. At Solv, we're seeing how the hard work and commitment of providers and public health officials paired with modern, simple and reliable technology can play a key role increasing the speed of vaccinations," said Heather Fernandez, CEO and Co-Founder of Solv. "Every day health departments, hospitals and clinics immediately overcome issues with their legacy scheduling technology when they quickly migrate to Solv's solution."

Built using Solv's on-demand scheduling platform, which has already booked over 5 million COVID-19 test appointments, Solv for Vaccines improves the end-to-end vaccination workflow--from patient eligibility pre-screening, to state immunization registry reporting. Delivered through a simple user experience, scheduling an appointment requires no logins, no downloads, and is accessible by all ages. Organizations migrating to Solv for Vaccines go-live in less than one week and can vaccinate thousands of patients per day at a single site.

"Vaccinating thousands of patients every day requires complex logistics and tight management of scheduling," said Kevin Brooks, COO of Swedish Health Services. "Switching our operation to Solv allowed us to dynamically match our vaccine capacity to the schedule, and communicate updates with patients. It's reducing no-shows and we deliver a great experience for patients."

Solv for Vaccines

Solv for Vaccines is easy-to-use for patients, regardless of their technical abilities. Patients can schedule and confirm an appointment online in less than a minute, without logging in or filling out long forms. With the Solv for Vaccines call center dashboard, organizations can easily schedule patients over the phone, extending their community reach. Solv's cloud-based solution is easy to configure and deploy quickly, so healthcare providers can get up and running in less than one week. Solv deploys new vaccination sites daily as more and more organizations discover the need to upgrade their logistics to meet the complex workflow and consumer demand for the COVID vaccine.

Solv for Vaccines includes:

"Solv allowed us to stand-up a COVID vaccine scheduling tool in under a week, helping us give thousands of vaccines to our staff, patients, and community," said Elizabeth Brock, Application PM at Seattle Cancer Care Alliance."Even better, the real-time patient feedback we receive from Solv allows us to quickly adjust our vaccine workflows and improve the patient experience."

Solv's COVID-19 Response

Solv for Vaccines builds upon Solv's COVID testing solution, which has been used to schedule more than 5 million covid tests in 2020.  More 14 million visitors use the Solv app every month to get and stay connected to the healthcare they need. Thousands of hospital systems, government organizations, private practices, urgent care centers, private practices, and community pop-up sites have leveraged Solv technology to support their testing initiatives. This proven and scalable scheduling and patient experience technology is now helping partners launch COVID vaccination sites in less than a week. New sites are being deployed daily.

About Solv

Solv is a consumer healthcare app that connects you to a national network of convenient healthcare providers, helping you to simplify your everyday healthcare needs. Solv partners with high-quality care providers across the country to make convenient care simple, friendly and transparent, the way it should be. The services and appointments offered on Solv are powered by a network of convenient care providers who use Solv's patient experience software to deliver a modern and delightful doctor's visit. This software increases community access to healthcare by improving the quality of service and the performance of the practice. More than 25 million doctor's appointments and more than 5 million COVID tests have been booked using Solv.

 

SOURCE Solv Health


These press releases may also interest you

at 01:00
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...

16 mai 2024
We are advised by Hidden River Eating Disorder Residential Treatment that journalists and other readers should disregard the news release, Hidden River Announces Insurance Contract with Blue Cross Blue Shield, issued 16-May-2024 over PR Newswire....

16 mai 2024
Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, today announced the appointment of Mark S. de Jong, PhD, to the newly created position of Chief Technical Officer (CTO). Dr. de Jong, joins Full-Life with 43...



News published on and distributed by: